Stockreport

SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment [Yahoo! Finance]

SAB Biotherapeutics, Inc.  (SABS) 
PDF biopharmaceutical company with a novel immunotherapy platform that is developing fully-human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression o [Read more]